A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining

Table 1

Summary of LUAD patient clinical characteristics.

Covariates	Group	Patients ()
			%
Survival time
Vital status	Alive	334	63.98
	Dead	188	36.02
Stage	I	280	53.64
	II	130	24.90
	III	86	16.48
	IV	26	4.98
T stage	T1	172	32.95
	T2	281	53.83
	T3	47	9.00
	T4	22	4.21
N stage	N0	342	65.52
	N1	99	18.97
	N2	75	14.37
	N3	6	1.15
M stage	M0	496	95.02
	M1	26	4.98
Age	≤65	250	47.89
	>65	272	52.11
Gender	Female	280	53.64
	Male	242	46.36